0
     

Report Added
Report already added
Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027

Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027

The global sinus dilation devices market is anticipated to reach USD 3.8 Billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 6.6% during the forecast period. The growth of the market is primarily driven by the factors such as growing extensiveness of chronic sinusitis and rising inclination of minimally invasive surgeries such as balloon sinuplasty.

“The Sinus stents/implants is projected to grow at highest CAGR of 8.2% from 2022 to 2027”
Based on the product, the sinus dilation devices market is classified into Balloon sinus dilation devices, Endoscopes (Sinuscopes, Rhinoscopes), Sinus stents/implants, and Handheld instruments. The growth of this market is majorly driven by the factors such as Advantages of balloon dilation procedures compared to traditional endoscopic sinus surgeries and Elevated regularity in chronic sinusitis.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the sinus dilation devices market is branched into four significant regional segments such as, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing per capita income and presence of low cost treatments.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
• By Designation: C-level (30%), Director-level (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)

List of Companies Profiled in the Report
•Acclarent, inc. (a subsidiary of Johnson & Johnson) (US)
•Olympus Corporation (Japan)
•Entellus Medical Inc. (A Subsidiary of Stryker) (US)
•Medtronic Plc. (Ireland)
•Smith & Nephew plc (UK)
•Intersect ENT, Inc. (US)
•SinuSys Corporation (US)
•InnAccel Pvt. Ltd (India)
•MERIL LIFE SCIENCES PVT Ltd. (India)
•Optim LLC (US)
•EMOS Technology GmbH (Germany)
•KARL STORZ (Germany)
•PENTAX Medical (Japan)
•Sklar Surgical Instruments (US)
•Dalent Medical (US).
•Angiplast Pvt. Ltd. (India)
•Summit Medical LLC. (US)
•Richard Wolf GmbH (Germany)
•Entermed (Germany)
•SCHÖLLY FIBEROPTIC GMBH (Germany)
•XION GmbH (Germany)
•Cook Medical (US)
•Maxer Endoscopy GmbH (Germany)
•ESC Medicams (India)
•Jilin Coronado Medical Ltd. (China)

Research Coverage:
This report studies the sinus dilation devices market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total sinus dilation devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on sinus dilation devices offered by the top 25 players in the sinus dilation devices market. The report analyzes the sinus dilation devices market by product, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the sinus dilation devices market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the sinus dilation devices market

Table of Contents

1INTRODUCTION25
1.1STUDY OBJECTIVES25
1.2MARKET DEFINITION25
1.2.1INCLUSIONS AND EXCLUSIONS26
1.3MARKET SCOPE26
1.3.1GEOGRAPHIC SCOPE27
1.3.2YEARS CONSIDERED27
1.4CURRENCY28
1.5LIMITATIONS28
1.6MARKET STAKEHOLDERS28
1.7SUMMARY OF CHANGES29
2RESEARCH METHODOLOGY30
2.1RESEARCH DATA30
FIGURE 1RESEARCH DESIGN30
2.1.1SECONDARY DATA31
2.1.1.1Secondary sources32
2.1.2PRIMARY DATA32
FIGURE 2PRIMARY SOURCES32
2.1.2.1Key data from primary sources33
2.1.2.2Key industry insights34
2.1.2.3Breakdown of primary interviews34
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS34
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION35
2.2MARKET SIZE ESTIMATION35
FIGURE 5REVENUE SHARE ANALYSIS ILLUSTRATION FOR JOHNSON & JOHNSON37
FIGURE 6MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH37
FIGURE 7MARKET SIZE ESTIMATION FROM PARENT MARKET38
2.2.1GROWTH FORECAST39
FIGURE 8CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS39
FIGURE 9TOP-DOWN APPROACH41
2.3MARKET BREAKDOWN AND DATA TRIANGULATION42
FIGURE 10DATA TRIANGULATION METHODOLOGY42
2.4MARKET SHARE ANALYSIS43
2.5STUDY ASSUMPTIONS43
2.6RISK ASSESSMENT43
TABLE 1RISK ASSESSMENT43
3EXECUTIVE SUMMARY44
FIGURE 11SINUS DILATION DEVICES MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)44
FIGURE 12ENDOSCOPES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)45
FIGURE 13SINUS DILATION DEVICES MARKET, BY PATIENT TYPE,
2022 VS. 2027 (USD MILLION)45
FIGURE 14SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING,
2022 VS. 2027 (USD MILLION)46
FIGURE 15SINUS DILATION DEVICES MARKET, BY PROCEDURE,
2022 VS. 2027 (USD MILLION)46
FIGURE 16GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET47
4PREMIUM INSIGHTS48
4.1SINUS DILATION DEVICES MARKET OVERVIEW48
FIGURE 17HIGH PREVALENCE OF CHRONIC SINUSITIS TO DRIVE MARKET48
4.2SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2022–202748
FIGURE 18HOSPITALS AND ASCS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD48
4.3ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT AND COUNTRY (2022)49
FIGURE 19BALLOON SINUS DILATION DEVICES SEGMENT TO DOMINATE ASIA PACIFIC MARKET IN 202249
4.4GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET50
FIGURE 20CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD50
5MARKET OVERVIEW51
5.1INTRODUCTION51
5.2MARKET DYNAMICS51
FIGURE 21SINUS DILATION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES51
5.2.1DRIVERS52
5.2.1.1High prevalence of chronic sinusitis52
5.2.1.2Benefits of balloon dilation procedures over traditional endoscopic sinus surgeries52
5.2.1.3Growing preference for minimally invasive surgeries54
5.2.1.4Rising healthcare expenditure54
FIGURE 22CURRENT HEALTH EXPENDITURE PER CAPITA54
FIGURE 23CURRENT HEALTH EXPENDITURE (% OF GDP)55
5.2.1.5Increasing availability of reimbursements55

5.2.2RESTRAINTS57
5.2.2.1Risks associated with sinus surgeries57
5.2.2.2Availability of non-surgical treatments for chronic sinusitis57
5.2.3OPPORTUNITIES58
5.2.3.1Growing healthcare market in emerging economies58
FIGURE 24GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRIC COUNTRIES, 2012–201960
5.2.4CHALLENGES60
5.2.4.1Dearth of skilled otolaryngologists, ENT surgeons, and endoscopists60
5.2.4.2Survival of small players and new entrants61
5.3RANGES/SCENARIOS61
FIGURE 25PESSIMISTIC SCENARIO61
FIGURE 26OPTIMISTIC SCENARIO62
FIGURE 27REALISTIC SCENARIO62
5.4VALUE CHAIN ANALYSIS63
FIGURE 28VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE63
5.5SUPPLY CHAIN ANALYSIS65
FIGURE 29DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES66
5.6TECHNOLOGY ANALYSIS66
TABLE 2BENEFITS OF ENDOSCOPIC PROCEDURE68
5.7PORTER’S FIVE FORCES ANALYSIS69
5.7.1THREAT OF NEW ENTRANTS69
5.7.2INTENSITY OF COMPETITIVE RIVALRY69
5.7.3BARGAINING POWER OF BUYERS69
5.7.4BARGAINING POWER OF SUPPLIERS69
5.7.5THREAT OF SUBSTITUTES69
5.8KEY STAKEHOLDERS AND BUYING CRITERIA71
5.8.1KEY STAKEHOLDERS IN BUYING PROCESS71
FIGURE 30INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS71
TABLE 3INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)71
5.8.2BUYING CRITERIA71
FIGURE 31KEY BUYING CRITERIA FOR END USERS71
TABLE 4KEY BUYING CRITERIA FOR END USERS72
5.9REGULATORY LANDSCAPE72
TABLE 5REGULATORY AUTHORITIES GOVERNING SINUS DILATION DEVICES MARKET72
5.10PATENT ANALYSIS76
5.11KEY CONFERENCES AND EVENTS77
TABLE 6LIST OF CONFERENCES AND EVENTS, 2022–202377
5.12PRICING ANALYSIS78
TABLE 7PRICE RANGE FOR SINUS DILATION DEVICES78
5.13TRADE ANALYSIS78
TABLE 8NUMBER OF EXPORTS AND IMPORTS RELATED TO ENDOSCOPY EQUIPMENT78
5.14ECOSYSTEM ANALYSIS79
TABLE 9ROLE IN ECOSYSTEM79
FIGURE 32KEY PLAYERS OPERATING IN SINUS DILATION DEVICES MARKET81
5.15TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES81
6SINUS DILATION DEVICES MARKET, BY PRODUCT82
6.1INTRODUCTION83
TABLE 10SINUS DILATION DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION)83
6.2BALLOON SINUS DILATION DEVICES83
6.2.1INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO SUPPORT MARKET83
TABLE 11BALLOON SINUS DILATION DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)84
6.3ENDOSCOPES84
TABLE 12ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)84
TABLE 13ENDOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)85
6.3.1SINUSCOPES85
6.3.1.1Largest and fastest-growing segment of endoscopes market85
TABLE 14SINUSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)85
6.3.2RHINOSCOPES86
6.3.2.1Primarily used to examine nasal cavity and passage86
TABLE 15RHINOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)86
6.4SINUS STENTS/IMPLANTS87
6.4.1SINUS STENTS/IMPLANTS ARE USED POSTOPERATIVELY FOLLOWING AN ENDOSCOPIC SINUS SURGERY87
TABLE 16SINUS STENTS/IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)87
6.5HANDHELD INSTRUMENTS87
6.5.1HANDHELD INSTRUMENTS ARE WIDELY USED IN ALMOST ALL KINDS OF SURGERIES87
TABLE 17HANDHELD INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)89
7SINUS DILATION DEVICES MARKET, BY PROCEDURE90
7.1INTRODUCTION91
TABLE 18SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)91

7.2STANDALONE SINUS DILATION PROCEDURES91
7.2.1STANDALONE SINUS DILATION PROCEDURES ARE WIDELY USED FOR SINUS DILATION91
TABLE 19STANDALONE SINUS DILATION PROCEDURES MARKET, BY REGION,
2020–2027 (USD MILLION)92
7.3HYBRID SINUS DILATION PROCEDURES92
7.3.1HYBRID SINUS DILATION PROCEDURES ARE MORE INVASIVE IN NATURE COMPARED TO STANDALONE PROCEDURES92
TABLE 20NUMBER OF SINUS PROCEDURES PERFORMED IN ENGLAND BETWEEN
2010 AND 201993
TABLE 21HYBRID SINUS DILATION PROCEDURES MARKET, BY REGION,
2020–2027 (USD MILLION)93
8SINUS DILATION DEVICES MARKET, BY PATIENT TYPE94
8.1INTRODUCTION95
TABLE 22SINUS DILATION DEVICES MARKET, BY PATIENT TYPE,
2020–2027 (USD MILLION)95
8.2ADULT PATIENTS95
8.2.1ADULT PATIENTS DOMINATE MARKET95
FIGURE 33THE PERCENTAGE DISTRIBUTION OF CHRONIC SINUSITIS BY AGE GROUP.95
TABLE 23ADULT SINUS DILATION DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)97
8.3PEDIATRIC PATIENTS97
8.3.1HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET97
FIGURE 34TIME OF ONSET OF CRS TO THE FIRST SURGICAL INTERVENTION FOR ENDOSCOPIC SINUS SURGERY PATIENTS.97
TABLE 24PEDIATRIC SINUS DILATION DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)98
9SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING99
9.1INTRODUCTION100
TABLE 25SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING,
2020–2027 (USD MILLION)100
9.2HOSPITALS AND AMBULATORY SURGERY CENTERS100
9.2.1LARGEST AND FASTEST-GROWING END USERS OF SINUS DILATION DEVICES100
TABLE 26SINUS DILATION DEVICES MARKET FOR HOSPITALS AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)101
9.3ENT CLINICS101
9.3.1FASTER RECOVERY TIME AND COST-EFFECTIVENESS ARE SUPPORTING SEGMENT GROWTH101
TABLE 27SINUS DILATION DEVICES MARKET FOR ENT CLINICS, BY REGION,
2020–2027 (USD MILLION)101

10SINUS DILATION DEVICES MARKET, BY REGION102
10.1INTRODUCTION103
TABLE 28SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)103
10.2NORTH AMERICA103
FIGURE 35NORTH AMERICA: SINUS DILATION DEVICES MARKET SNAPSHOT104
TABLE 29NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)104
TABLE 30NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)105
TABLE 31NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)105
TABLE 32NORTH AMERICA: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 33NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)105
TABLE 34NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)106
10.2.1US106
10.2.1.1Favorable reimbursement scenario for sinus dilation procedures106
TABLE 35US: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)107
TABLE 36US: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)107
TABLE 37US: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)107
10.2.2CANADA107
10.2.2.1Rising geriatric population and associated increase in prevalence of CRS to support market growth107
TABLE 38CANADA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)108
TABLE 39CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)108
TABLE 40CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)108
10.3EUROPE109
TABLE 41EUROPE: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)109
TABLE 42EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)109
TABLE 43EUROPE: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)110
TABLE 44EUROPE: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 45EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)110
TABLE 46EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)110
10.3.1GERMANY111
10.3.1.1Rising geriatric population and increasing R&D—key factors driving market111
TABLE 47GERMANY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)111
TABLE 48GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)112
TABLE 49GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)112
10.3.2UK112
10.3.2.1Fastest-growing market for sinus dilation devices in Europe112
TABLE 50UK: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)113
TABLE 51UK: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)113
TABLE 52UK: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)113
10.3.3FRANCE114
10.3.3.1High burden of chronic sinusitis to drive market114
TABLE 53FRANCE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)114
TABLE 54FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)114
TABLE 55FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)115
10.3.4ITALY115
10.3.4.1Growing geriatric population to support adoption of sinus dilation devices115
TABLE 56ITALY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)115
TABLE 57ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)117
TABLE 58ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)117
10.3.5SPAIN117
10.3.5.1Rising healthcare expenditure to support market for sinus dilation devices117
TABLE 59SPAIN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)118
TABLE 60SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)118
TABLE 61SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)118
10.3.6REST OF EUROPE118
TABLE 62REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)119
TABLE 63REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)119
TABLE 64REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)119
10.4ASIA PACIFIC120
FIGURE 36ASIA PACIFIC: SINUS DILATION DEVICES MARKET SNAPSHOT121
TABLE 65ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 66ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)122
TABLE 67ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)122
TABLE 68ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)122
TABLE 69ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)122
TABLE 70ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)123
10.4.1CHINA123
10.4.1.1Fastest-growing market for sinus dilation devices123
TABLE 71CHINA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)123
TABLE 72CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)124
TABLE 73CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)124
10.4.2JAPAN124
10.4.2.1Large geriatric population to aid market growth124
TABLE 74JAPAN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)125
TABLE 75JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)125
TABLE 76JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)125
10.4.3INDIA125
10.4.3.1High prevalence of sinusitis will drive demand for sinus dilation devices125
TABLE 77INDIA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)126
TABLE 78INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)126
TABLE 79INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)126
10.4.4REST OF ASIA PACIFIC126
TABLE 80REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)127
TABLE 81REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)127
TABLE 82REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)128
10.5REST OF THE WORLD128
TABLE 83REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)128
TABLE 84REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)129
TABLE 85REST OF THE WORLD: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 86REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)129
TABLE 87REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)129
11COMPETITIVE LANDSCAPE131
11.1OVERVIEW131
11.2KEY PLAYER STRATEGIES/RIGHT TO WIN131
TABLE 88OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINUS DILATION DEVICES MARKET131
11.3REVENUE SHARE ANALYSIS132
FIGURE 37REVENUE ANALYSIS OF KEY PLAYERS IN SINUS DILATION DEVICES MARKET132
11.4MARKET SHARE ANALYSIS132
TABLE 89SINUS DILATION DEVICES MARKET: DEGREE OF COMPETITION133
11.5COMPANY EVALUATION QUADRANT134
11.5.1STARS134
11.5.2EMERGING LEADERS134
11.5.3PERVASIVE PLAYERS134
11.5.4PARTICIPANTS134
FIGURE 38COMPANY EVALUATION QUADRANT: SINUS DILATION DEVICES MARKET135
11.6COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS136
11.6.1PROGRESSIVE COMPANIES136
11.6.2STARTING BLOCKS136
11.6.3RESPONSIVE COMPANIES136
11.6.4DYNAMIC COMPANIES136
FIGURE 39COMPANY EVALUATION MATRIX FOR SMES/STARTUPS: SINUS DILATION DEVICES MARKET137
11.7COMPANY FOOTPRINT ANALYSIS138
TABLE 90FOOTPRINT OF COMPANIES IN SINUS DILATION DEVICES MARKET138
TABLE 91REGIONAL FOOTPRINT OF COMPANIES140
TABLE 92PRODUCT FOOTPRINT OF COMPANIES142
11.8COMPETITIVE BENCHMARKING144
TABLE 93SINUS DILATION DEVICES MARKET: LIST OF KEY STARTUPS/SMES144
11.9COMPETITIVE SCENARIO145
11.9.1PRODUCT LAUNCHES/APPROVALS145
TABLE 94KEY PRODUCT LAUNCHES145
11.9.2DEALS145
TABLE 95KEY DEALS145
11.9.3OTHER DEVELOPMENTS147
TABLE 96OTHER KEY DEVELOPMENTS147
12COMPANY PROFILES148
12.1KEY PLAYERS148
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1ENTELLUS MEDICAL, INC. (SUBSIDIARY OF STRYKER)148
TABLE 97STRYKER: BUSINESS OVERVIEW148
FIGURE 40STRYKER: COMPANY SNAPSHOT (2021)149
12.1.2MEDTRONIC PLC154
TABLE 98MEDTRONIC PLC: BUSINESS OVERVIEW154
FIGURE 41MEDTRONIC PLC: COMPANY SNAPSHOT (2022)155
12.1.3ACCLARENT, INC. (SUBSIDIARY OF JOHNSON & JOHNSON)159
TABLE 99JOHNSON & JOHNSON: BUSINESS OVERVIEW159
FIGURE 42JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)160
12.1.4SMITH & NEPHEW PLC163
TABLE 100SMITH & NEPHEW PLC: BUSINESS OVERVIEW163
FIGURE 43SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)164
12.1.5INTERSECT ENT, INC.166
TABLE 101INTERSECT ENT, INC.: BUSINESS OVERVIEW166
FIGURE 44INTERSECT ENT, INC.: COMPANY SNAPSHOT (2021)166
12.1.6OLYMPUS CORPORATION169
TABLE 102OLYMPUS CORPORATION: BUSINESS OVERVIEW169
FIGURE 45OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)170
12.1.7SINUSYS CORPORATION173
TABLE 103SINUSYS CORPORATION: BUSINESS OVERVIEW173
12.1.8INNACCEL TECHNOLOGIES PVT LTD.174
TABLE 104INNACCEL TECHNOLOGIES PVT LTD.: BUSINESS OVERVIEW174
12.1.9MERIL LIFE SCIENCES PVT. LTD.175
TABLE 105MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW175
12.1.10OPTIM LLC176
TABLE 106OPTIM LLC: BUSINESS OVERVIEW176
12.2OTHER PLAYERS177
12.2.1JILIN CORONADO MEDICAL LTD.177
TABLE 107JILIN CORONADO MEDICAL LTD.: BUSINESS OVERVIEW177
12.2.2DALENT MEDICAL178
TABLE 108DALENT MEDICAL: BUSINESS OVERVIEW178
12.2.3EMOS TECHNOLOGY GMBH179
TABLE 109EMOS TECHNOLOGY GMBH: BUSINESS OVERVIEW179
12.2.4SKLAR SURGICAL INSTRUMENTS180
TABLE 110SKLAR SURGICAL INSTRUMENTS: BUSINESS OVERVIEW180
12.2.5KARL STORZ181
TABLE 111KARL STORZ: BUSINESS OVERVIEW181
12.2.6PENTAX MEDICAL182
TABLE 112PENTAX MEDICAL: BUSINESS OVERVIEW182
12.2.7ANGIPLAST PVT. LTD.183
TABLE 113ANGIPLAST PVT. LTD.: BUSINESS OVERVIEW183
12.2.8SUMMIT MEDICAL LLC184
TABLE 114SUMMIT MEDICAL LLC: BUSINESS OVERVIEW184
12.2.9RICHARD WOLF GMBH185
TABLE 115RICHARD WOLF GMBH: BUSINESS OVERVIEW185
12.2.10ENTERMED186
TABLE 116ENTERMED: BUSINESS OVERVIEW186
12.2.11SCHÖLLY FIBEROPTIC GMBH187
TABLE 117SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW187
12.2.12XION GMBH188
TABLE 118XION GMBH: BUSINESS OVERVIEW188
12.2.13COOK MEDICAL189
TABLE 119COOK MEDICAL: BUSINESS OVERVIEW189
12.2.14MAXER ENDOSCOPY GMBH190
TABLE 120MAXER ENDOSCOPY GMBH: BUSINESS OVERVIEW190
12.2.15ESC MEDICAMS191
TABLE 121ESC MEDICAMS: BUSINESS OVERVIEW191
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13APPENDIX192
13.1INDUSTRY INSIGHTS192
13.2DISCUSSION GUIDE193
13.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL197
13.4CUSTOMIZATION OPTIONS199
13.5RELATED REPORTS199
13.6AUTHOR DETAILS200

Report Title: Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM